Prescribing information

 

________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Currently there are differences in the dosing between Great Britain (GB) (England, Scotland, Wales) and Northern Ireland (NI).

 

Please see prescribing information for
Great Britain below

GB prescribing information

Please see prescribing information for
Northern Ireland below

NI prescribing information

 
Rate this content: 
No votes yet
UK | September 2021 | 157291
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]